Eric I. Richman, Director at ADMA BIOLOGICS, INC. (ADMA), bought 5,230 shares at $4.78 ($25K) on 2018-06-08, disclosed to the SEC on 2018-06-11.
Open-market purchase of $25k ADMA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| GANX | BUY | 2022-05-23 | $37K | — | Filing → |
| NBSE | BUY | 2022-03-07 | $6K | — | Filing → |
| NBSE | BUY | 2021-04-27 | $25K | — | Filing → |